This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA393216; GEO: GSE100842 |
| Type | Umbrella project |
| Publications | Shibata H et al., "In vivo reprogramming drives Kras-induced cancer development.", Nat Commun, 2018 May 25;9(1):2081 |
| Submission | Registration date: 5-Jul-2017
Division of Stem Cell Pathology, Institute of Medical Science, University of Tokyo |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 14 |
| Publications |
| PubMed | 1 |
| PMC | 1 |
| Other datasets |
| BioSample | 14 |
| GEO DataSets | 3 |
GEO Data Details| Parameter | Value |
|---|
| Data volume, Spots | 230824 |
| Data volume, Processed Mbytes | 5 |
| Data volume, Supplementary Mbytes | 39395 |
| Parameter | Value |
|---|
| Data volume, Gbases | 43 |
| Data volume, Mbytes | 15782 |
In vivo reprogramming drives Kras-induced cancer development encompasses the following 2 sub-projects:
| Project Type | Number of Projects |
| Epigenomics | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA393221 | Mus musculus | In vivo reprogramming drives Kras-induced cancer development [ChIP-seq] (Division of Stem Cell Pathology,...) |
|
| Transcriptome or Gene expression | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA393220 | Mus musculus | In vivo reprogramming drives Kras-induced cancer development [expression] (Division of Stem Cell Pathology,...) |
|